Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT06292312

Investigation of the Effectiveness of Craniosacral Therapy in Patients With Multiple Sclerosis.

Led by Ankara Yildirim Beyazıt University · Updated on 2024-07-30

32

Participants Needed

1

Research Sites

63 weeks

Total Duration

On this page

Sponsors

A

Ankara Yildirim Beyazıt University

Lead Sponsor

L

Lokman Hekim University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Although the cause of Multiple Sclerosis (MS), one of the common demyelinating diseases of the central nervous system, has not yet been fully elucidated, autonomic nervous system dysfunction has been suggested in its etiology. Symptoms such as fatigue, problems with bladder, bowel, cardiovascular, sleep, sexual and sweating functions, abnormal sympathetic skin response or decreased heart rate variation support this hypothesis. In the treatment of many neurological diseases such as Multiple Sclerosis, complementary medicine practices and non-traditional therapies have recently been shown to be effective in addition to conventional practices. One of these practices, craniosacral therapy (CST), uses manual palpation and manipulation of the craniosacral system to influence sensory, motor, cognitive and emotional processes in the nervous system. In addition, it is thought that applying external force to certain bone elements can have a positive effect on various symptoms in patients with MS, based on the knowledge that it can be transmitted within the system.

CONDITIONS

Official Title

Investigation of the Effectiveness of Craniosacral Therapy in Patients With Multiple Sclerosis.

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 65 years
  • Definitive diagnosis of Multiple Sclerosis by a neurologist
  • EDSS score between 1 and 5.5
  • Not receiving active physical therapy services
  • Volunteering to participate in the study
Not Eligible

You will not qualify if you...

  • Having a neurological disease other than Multiple Sclerosis
  • MS attacks in the last three months
  • Use of corticosteroids
  • History of spine surgery
  • Central or peripheral nervous system disease
  • Pregnancy
  • Oncological diseases
  • Severe somatic or psychiatric disorders
  • Receiving invasive or manipulative treatments

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ankara Yıldırım Beyazıt University

Ankara, Turkey (Türkiye), 06010

Actively Recruiting

Loading map...

Research Team

H

Hilal Aslan, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here